Your browser is no longer supported. Please, upgrade your browser.
FLDM Fluidigm Corporation monthly Stock Chart
Fluidigm Corporation
Index- P/E- EPS (ttm)-0.79 Insider Own0.80% Shs Outstand70.46M Perf Week-13.87%
Market Cap279.12M Forward P/E- EPS next Y-0.62 Insider Trans24.00% Shs Float69.80M Perf Month-2.53%
Income-55.30M PEG- EPS next Q-0.22 Inst Own92.20% Short Float2.53% Perf Quarter23.00%
Sales114.70M P/S2.43 EPS this Y34.80% Inst Trans0.97% Short Ratio1.02 Perf Half Y61.09%
Book/sh2.01 P/B1.92 EPS next Y6.90% ROA-20.00% Target Price7.20 Perf Year-72.83%
Cash/sh0.67 P/C5.76 EPS next 5Y-8.06% ROE-35.10% 52W Range1.17 - 14.30 Perf YTD10.63%
Dividend- P/FCF- EPS past 5Y12.60% ROI-29.90% 52W High-73.07% Beta2.00
Dividend %- Quick Ratio1.90 Sales past 5Y0.10% Gross Margin55.50% 52W Low229.06% ATR0.54
Employees566 Current Ratio2.30 Sales Q/Q-8.30% Oper. Margin-48.50% RSI (14)46.35 Volatility9.20% 13.44%
OptionableYes Debt/Eq0.38 EPS Q/Q48.00% Profit Margin-48.20% Rel Volume0.96 Prev Close4.29
ShortableYes LT Debt/Eq0.38 EarningsMay 07 AMC Payout- Avg Volume1.73M Price3.85
Recom2.20 SMA20-15.94% SMA5018.93% SMA2004.14% Volume1,662,465 Change-10.26%
Nov-06-19Downgrade Janney Buy → Neutral
Oct-18-19Upgrade UBS Neutral → Buy $14 → $7
Mar-15-19Initiated UBS Neutral $14
Jan-03-19Upgrade Janney Neutral → Buy
Nov-02-18Upgrade Piper Jaffray Neutral → Overweight
Aug-05-16Reiterated Mizuho Buy $11 → $12
Aug-05-16Reiterated Cantor Fitzgerald Buy $13 → $11
May-05-16Reiterated Mizuho Buy $8 → $11
Apr-12-16Reiterated Leerink Partners Outperform $20 → $15
Jan-07-16Initiated Deutsche Bank Buy $18
Oct-30-15Upgrade Cantor Fitzgerald Hold → Buy $15 → $12
Oct-30-15Reiterated Mizuho Neutral $15 → $8
Aug-27-15Initiated Cantor Fitzgerald Hold
Aug-07-15Reiterated Mizuho Neutral $30 → $15
Aug-07-15Downgrade Piper Jaffray Overweight → Neutral
May-08-15Reiterated Maxim Group Buy $52 → $44
May-08-15Downgrade Mizuho Buy → Neutral $50 → $30
May-06-14Reiterated Maxim Group Buy $65 → $52
Apr-23-14Upgrade Mizuho Neutral → Buy $43 → $50
Mar-21-14Reiterated Maxim Group Buy $52 → $65
May-19-20 08:30AM  
May-13-20 04:02PM  
May-12-20 11:44AM  
May-09-20 11:01PM  
May-08-20 07:35PM  
May-07-20 04:05PM  
Apr-23-20 08:30AM  
Apr-20-20 04:06PM  
Apr-14-20 04:05PM  
Apr-08-20 09:44AM  
Apr-02-20 08:30AM  
Mar-16-20 08:30AM  
Mar-13-20 08:05AM  
Mar-11-20 08:30AM  
Mar-10-20 08:30AM  
Mar-03-20 08:00AM  
Feb-26-20 08:30AM  
Feb-13-20 08:10AM  
Feb-12-20 04:05PM  
Feb-10-20 06:35PM  
Feb-03-20 12:30PM  
Jan-30-20 07:28AM  
Jan-20-20 11:32AM  
Jan-14-20 08:30AM  
Jan-13-20 08:30AM  
Dec-18-19 08:30AM  
Dec-16-19 07:12AM  
Dec-12-19 08:30AM  
Dec-10-19 08:30AM  
Dec-09-19 08:30AM  
Dec-08-19 04:22PM  
Nov-20-19 11:21AM  
Nov-13-19 04:05PM  
Nov-10-19 03:29PM  
Nov-07-19 05:37PM  
Nov-05-19 07:55PM  
Nov-01-19 08:17AM  
Oct-29-19 10:33AM  
Oct-28-19 08:23PM  
Oct-15-19 04:15PM  
Oct-10-19 04:10PM  
Sep-26-19 09:16AM  
Sep-24-19 08:30AM  
Sep-18-19 08:30AM  
Sep-10-19 07:30AM  
Sep-09-19 08:30AM  
Sep-04-19 08:30AM  
Aug-27-19 08:30AM  
Aug-21-19 07:48AM  
Aug-20-19 04:05PM  
Aug-05-19 05:44PM  
Aug-02-19 01:15PM  
Aug-01-19 04:05PM  
Jul-30-19 08:30AM  
Jul-25-19 10:33AM  
Jul-08-19 07:45AM  
Jul-03-19 01:05PM  
Jun-20-19 08:30AM  
Jun-19-19 08:30AM  
Jun-17-19 08:30AM  
Jun-04-19 08:30AM  
May-31-19 05:37PM  
May-29-19 08:45AM  
May-12-19 09:47PM  
May-10-19 04:05PM  
May-09-19 08:30AM  
May-06-19 08:00PM  
May-04-19 09:15AM  
May-03-19 02:38PM  
May-02-19 08:35PM  
May-01-19 10:26AM  
Apr-30-19 09:00AM  
Apr-29-19 09:41AM  
Apr-25-19 10:34AM  
Apr-23-19 06:00AM  
Apr-08-19 03:55PM  
Apr-05-19 09:40AM  
Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research worldwide. It offers analytical systems comprising Helios, a CyTOF system, Hyperion imaging system, and Hyperion tissue imager; and assays and reagents, including Maxpar reagents and Maxpar human immune monitoring panel kit and workflow., as well as Maxpar direct immune profiling assays and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 system, Polaris system, C1 IFCs, and Polaris IFC. It sells instruments, consumables, and services to academic institutions, clinical research laboratories, and contract research organizations, as well as biopharmaceutical, biotechnology, and agricultural biotechnology companies. Fluidigm Corporation sells its products to academic institutions, life sciences, and clinical research laboratories that conduct research, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Linthwaite Stephen ChristopherPresident & CEOMay 20Option Exercise0.0019,4440216,037May 22 06:29 PM
JOG VIKRAMChief Financial OfficerMay 20Option Exercise0.006,650059,412May 22 06:29 PM
Kreger Bradley AllenSVP, Global OperationsMay 20Option Exercise0.005,361024,762May 22 06:28 PM
McCracken ColinChief Commercial OfficerMay 20Option Exercise0.0016,516022,023May 22 06:29 PM
Paya Carlos VDirectorMar 23Option Exercise0.002,500043,343Mar 25 05:25 PM
BARTHELEMY NICOLASDirectorMar 23Option Exercise0.002,5000151,873Mar 25 05:25 PM
COLELLA SAMUEL DDirectorMar 11Buy2.6510,00026,545161,109Mar 12 09:28 PM
COLELLA SAMUEL DDirectorMar 10Buy2.7710,00027,738151,109Mar 12 09:28 PM
BARTHELEMY NICOLASDirectorMar 06Buy3.0580,000243,872149,373Mar 10 06:59 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERFeb 20Option Exercise0.0013,585058,317Feb 24 07:07 PM
Linthwaite Stephen ChristopherPresident & CEOFeb 20Option Exercise0.0040,0900217,717Feb 24 05:05 PM
Khadder NicholasSee RemarksFeb 20Option Exercise0.0013,159058,022Feb 24 05:06 PM
Kreger Bradley AllenSVP, Global OperationsFeb 20Option Exercise0.0012,071024,336Feb 24 05:05 PM
BARTHELEMY NICOLASDirectorFeb 13Buy3.6412,25744,61469,373Feb 18 08:33 PM
Kreger Bradley AllenSVP, Global OperationsNov 20Option Exercise0.003,125013,346Nov 22 08:43 PM
Linthwaite Stephen ChristopherPresident & CEONov 20Option Exercise0.0012,5620183,953Nov 22 08:33 PM
Khadder NicholasSee RemarksNov 20Option Exercise0.004,901045,431Nov 22 08:30 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERNov 20Option Exercise0.004,751046,376Nov 22 08:28 PM
Levin Easterly Partners LLCPassive InvestorSep 17Sale5.40577,1973,116,8646,909,871Sep 19 04:27 PM
Levin Easterly Partners LLCPassive InvestorSep 11Sale5.5511,54564,1127,487,068Sep 13 04:22 PM
COLELLA SAMUEL DDirectorAug 27Buy5.192,00010,372119,481Aug 28 09:13 PM
Linthwaite Stephen ChristopherPresident & CEOAug 23Buy5.524,00022,077171,391Aug 27 07:58 PM
Linthwaite Stephen ChristopherPresident & CEOAug 20Option Exercise0.0012,5620173,717Aug 22 05:55 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERAug 20Option Exercise0.004,751043,269Aug 22 05:54 PM
Kreger Bradley AllenSVP, Global OperationsAug 20Option Exercise0.003,125011,302Aug 22 05:54 PM
Khadder NicholasSee RemarksAug 20Option Exercise0.004,901042,962Aug 22 05:54 PM
Levin Easterly Partners LLCPassive InvestorAug 13Sale7.01151,0111,059,2828,271,611Aug 15 05:41 PM
COLELLA SAMUEL DDirectorAug 08Buy6.651,0006,653117,481Aug 12 04:57 PM
COLELLA SAMUEL DDirectorAug 07Buy6.861,0006,857116,481Aug 08 09:04 PM
Levin Easterly Partners LLCPassive InvestorAug 07Sale6.90129,237892,0609,840,084Aug 12 05:05 PM
COLELLA SAMUEL DDirectorAug 06Buy7.028,00056,183115,481Aug 08 09:04 PM
Levin Easterly Partners LLCPassive InvestorAug 01Sale12.251,62919,9569,969,321Aug 05 03:59 PM
Levin Easterly Partners LLCPassive InvestorJul 29Sale11.9782,585988,4609,970,950Jul 29 04:50 PM
Levin Easterly Partners LLCPassive InvestorJul 26Sale11.92195,9822,335,30210,053,535Jul 29 04:50 PM
Levin Easterly Partners LLCPassive InvestorJul 25Sale11.859,405111,48010,249,517Jul 29 04:50 PM
Levin Easterly Partners LLCPassive InvestorJul 24Sale11.7828,090330,99910,258,922Jul 24 05:01 PM
Levin Easterly Partners LLCPassive InvestorJul 23Sale11.5818,601215,41810,287,012Jul 24 05:01 PM
Levin Easterly Partners LLCPassive InvestorJul 22Sale11.5761,432710,90310,305,613Jul 24 05:01 PM
Levin Easterly Partners LLCPassive InvestorJul 19Sale11.5083,728963,12310,367,045Jul 19 04:21 PM
Levin Easterly Partners LLCPassive InvestorJul 18Sale11.50179,8532,068,30310,450,773Jul 19 04:21 PM
Levin Easterly Partners LLCPassive InvestorJul 17Sale11.32134,4871,522,17810,630,626Jul 19 04:21 PM
Levin Easterly Partners LLCPassive InvestorJul 01Sale12.3329,410362,77110,765,113Jul 02 04:35 PM
Levin Easterly Partners LLCPassive InvestorJun 28Sale12.30157,3491,935,48710,794,523Jul 02 04:35 PM
Levin Easterly Partners LLCPassive InvestorJun 25Sale12.2325,452311,38710,951,872Jun 27 06:04 PM
Levin Easterly Partners LLCPassive InvestorJun 24Sale12.29191,6962,355,27310,976,694Jun 27 06:04 PM
COLELLA SAMUEL DDirectorJun 20Option Exercise6.1323,600144,762107,481Jun 24 09:14 PM
BARTHELEMY NICOLASDirectorJun 17Sale12.435,10063,39841,849Jun 19 04:36 PM